William Blair analyst Matt Phipps upgraded Genmab A/S (NASDAQ: GMAB) from Market Perform to Outperform.The analyst comments: "On Monday, March ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE